Drugs / 68Ga-PSMA-cyclotron
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT04685811 | Dec 2020 → Jun 2021 | prostate adenocarcinoma | Weill Medical College of Cornell University | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 68Ga-PSMA-cyclotron | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04685811 ↗ |
| Modality | Small molecule | “68Ga Small Molecule PSMA Antagonist Produced by Two Different Methods” NCT04685811 ↗ |